MedTrace Logo

Post-Approval Study of the TREO Abdominal Stent-Graft System

NCT04697784 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 338

Last updated 2025-06-26

No results posted yet for this study

Summary

The purpose of this study is to determine the long-term performance of the TREO Abdominal Stent-Graft as a treatment for patients with Infrarenal Abdominal Aortic Aneurysms or Aorto-iliac Aneurysms.

Conditions

  • Abdominal Aortic Aneurysm

Interventions

DEVICE

TREO Abdominal Stent-Graft System

The TREO Abdominal Stent-Graft System is intended for the treatment of infrarenal abdominal aortic aneurysms with or without iliac involvement.

Sponsors & Collaborators

  • Bolton Medical

    lead INDUSTRY

Principal Investigators

  • Gretchen Wild · Terumo Aortic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-20
Primary Completion
2027-07-31
Completion
2027-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04697784 on ClinicalTrials.gov